NeuroLambda Therapeutics, Inc. — Form D
NeuroLambda Therapeutics, Inc. of Cambridge, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-07-17. The offering totals $5.0M, of which $3.0M was reported sold. Industry: Other Technology.
Offering
- Filed: 2024-07-17
- Form: D
- Accession: 0002029691-24-000002
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $3.0M
- Remaining: $2.0M
- Investors: 1
- Date of first sale: 2024-06-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-519102
Issuer
- Name: NeuroLambda Therapeutics, Inc.
- CIK: 0002029691
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 1 Broadway, 14th Floor, Cambridge, MA, 02142
- Phone: 929-375-5755
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Xiaowei Jin | Director | Cambridge, MA |
| Byungchan Kim | Director | Cambridge, MA |
| Sayan Mondal | Director | Cambridge, MA |
| Sayan Mondal | Executive Officer | Cambridge, MA |
More